These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21150766)

  • 1. Adipocytes and cardiometabolic risk.
    Allende-Vigo MZ
    Am J Ther; 2012 Jul; 19(4):294-9. PubMed ID: 21150766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiologic mechanisms linking adipose tissue and cardiometabolic risk.
    Allende-Vigo MZ
    Endocr Pract; 2010; 16(4):692-8. PubMed ID: 20439246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction in obesity: etiological role in atherosclerosis.
    Meyers MR; Gokce N
    Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):365-9. PubMed ID: 17940464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds.
    Grundy SM
    J Am Coll Cardiol; 2006 Mar; 47(6):1093-100. PubMed ID: 16545636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome.
    Vitale C; Marazzi G; Volterrani M; Aloisio A; Rosano G; Fini M
    Minerva Med; 2006 Jun; 97(3):219-29. PubMed ID: 16855517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-based cardiometabolic risk evaluation in minority and non-minority men grading the evidence of non-traditional determinants of cardiovascular risk.
    Billups KL; Miner MM; Wierzbicki AS; Jackson G
    Int J Clin Pract; 2011 Feb; 65(2):134-47. PubMed ID: 21199197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipokines--targeting a root cause of cardiometabolic risk.
    Bakhai A
    QJM; 2008 Oct; 101(10):767-76. PubMed ID: 18550581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory assessment of cardiometabolic risk in overweight and obese children.
    Sypniewska G
    Clin Biochem; 2015 Apr; 48(6):370-6. PubMed ID: 25583095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking resistin, inflammation, and cardiometabolic diseases.
    Park HK; Kwak MK; Kim HJ; Ahima RS
    Korean J Intern Med; 2017 Mar; 32(2):239-247. PubMed ID: 28192887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges associated with metabolic syndrome.
    Spinler SA
    Pharmacotherapy; 2006 Dec; 26(12 Pt 2):209S-217S. PubMed ID: 17125447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of cardiometabolic risk factor clusters on health-related quality of life in the U.S.
    Sullivan PW; Ghushchyan V; Wyatt HR; Wu EQ; Hill JO
    Obesity (Silver Spring); 2007 Feb; 15(2):511-21. PubMed ID: 17299125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome.
    Otani H
    Antioxid Redox Signal; 2011 Oct; 15(7):1911-26. PubMed ID: 21126197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between hyperinsulinemia, hypertension and progressive renal disease.
    El-Atat FA; Stas SN; McFarlane SI; Sowers JR
    J Am Soc Nephrol; 2004 Nov; 15(11):2816-27. PubMed ID: 15504934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity, inflammation, and cardiovascular risk.
    Mathieu P; Lemieux I; Després JP
    Clin Pharmacol Ther; 2010 Apr; 87(4):407-16. PubMed ID: 20200516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of vitamin D status and cardiometabolic risk factors in children and adolescents.
    Salo A; Logomarsino JV
    Pediatr Endocrinol Rev; 2011 Sep; 9(1):456-62. PubMed ID: 22783643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose tissue, insulin resistance and low-grade inflammation: implications for atherogenesis and the cardiovascular harm of estrogen plus progestogen therapy.
    Tankó LB; Christiansen C
    Climacteric; 2006 Jun; 9(3):169-80. PubMed ID: 16766431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement C3 and cleavage products in cardiometabolic risk.
    Onat A; Can G; Rezvani R; Cianflone K
    Clin Chim Acta; 2011 Jun; 412(13-14):1171-9. PubMed ID: 21419112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiometabolic risk and female sexual health: the Princeton III summary.
    Miner M; Esposito K; Guay A; Montorsi P; Goldstein I
    J Sex Med; 2012 Mar; 9(3):641-51; quiz 652. PubMed ID: 22372651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.